Publish in this journal
Journal Information
Vol. 75. Issue 5.
Pages 442-443 (May 2022)
Not available
Vol. 75. Issue 5.
Pages 442-443 (May 2022)
Image in cardiology
Full text access
Apixaban and intraventricular thrombus resolution in a patient with an AMI
Apixabán y resolución de trombo intraventricular en un paciente con IAM
Gloria María Heredia Campos
Corresponding author

Corresponding author:.
, Jorge Perea Armijo, Manuel Anguita Sánchez
Servicio de Cardiología, Hospital Universitario Reina Sofía, Córdoba, Spain
This item has received
Article information
Full Text
Download PDF
Figures (3)
Show moreShow less
Additional material (4)
Full Text

A 78-year-old man, who was an active smoker, presented with a 2-week history of chest pain, dyspnea and orthopnea. On examination, he was tachypneic and had bilateral basal crepitations. Chest X-ray showed bilateral alveolar edema, and blood tests revealed raised troponin and NT-proBNP. Electrocardiogram showed ST elevation in V1 to V5 and Q waves, compatible with acute pulmonary edema secondary to acute evolving anterior myocardial infarction. Transthoracic echocardiogram (figure 1, videos 1 and 2 of the supplementary data) showed a dilated left ventricle with a large dyskinetic apical region with a hyperechoic image within it (8×6 cm), indicative of intraventricular thrombus, and a left ventricular ejection fraction of 25%. Computed tomography (figure 2) showed a large apical thrombus in the left ventricle (3.1×6.2×9.6cm) occupying at least 50% of the cavity.

Figure 1
Figure 2

After finding some cases in the literature of intraventricular thrombus treated with direct oral anticoagulants (DOACs), the medical team decided to start anticoagulation with apixaban 5 mg/12h.

The patient progressed well. One month after discharge, repeat echocardiogram showed no thrombus but persistence of the large apical aneurysm with slow flow through it (figure 3, videos 3 and 4 of the supplementary data).

Figure 3

Although the usual treatment is with heparin or vitamin K antagonists and there are no randomized clinical trials with DOACs, this case demonstrates the effectiveness of apixaban in resolving a large intraventricular thrombus in 6 weeks. Informed consent was obtained prior to publication.




G.M. Heredia Campos wrote the case report. J. Perea Armijo was responsible for the investigations. M. Anguita Sánchez had a supervisory role.




Supplementary data associated with this article can be found in the online version available at

Appendix B


Copyright © 2021. Sociedad Española de Cardiología
Revista Española de Cardiología (English Edition)

Subscribe to our newsletter

View newsletter history
Article options
Supplemental materials
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?